Screening | Who needs it | How often |
|---|
Chlamydia and gonorrhea infections | Sexually active females up to age 24 years | Once a year |
High lead level | Children who are 6 years of age and younger | Questions to determine risk or blood tests may be done once a year |
HIV | Children in this age group at risk for infection; talk with your child’s healthcare provider | At routine exams |
Obesity | Assessment of obesity risk for all patients | At routine exams |
Tooth decay and other dental problems | All children in this age group | Dental exams every 6 months; fluoride supplements from age 6 months to 16 years for those with low fluoride levels in their water; fluoride varnish should be applied every 3 to 6 months; fluoride rinses may be used in children age 6 years or older, if they are able to rinse and spit |
Type 2 diabetes or prediabetes | Children age 10 or over who are overweight or obese and have 2 or more additional diabetes risk factors | Every 3 years |
Blood pressure | All children 3 years of age and older | Annual well child visit |
Vision problems | All children in this age group | Screening once between ages 3 and 5 years |
Vaccines | Who needs it | How often |
|---|
DTaP (diphtheria, tetanus, acellular pertussis) | All children under age 7 years | Booster between ages 4 and 6 years |
Tdap (tetanus, diphtheria, acellular pertussis) | All children age 7 years or older | Booster between ages 11 and 12 years |
Chickenpox (varicella) | Children who have not had chickenpox | Booster between ages 4 and 6 years |
Hepatitis A | Children at risk (talk with your child’s healthcare provider) or those who didn’t have the vaccine at an earlier age | Should be fully vaccinated by age 2; if not, can have vaccine at routine visits, with second dose given at least 6 months after first dose |
Hepatitis B | Children who didn’t have the vaccine at an earlier age | 3-dose series: The second dose is given 4 weeks after the first dose, and the final dose is given 16 weeks after the first dose
2-dose series: For children ages 11 to 15, 2 doses are given at least 4 months apart |
Human papillomavirus (HPV) | Children age 11 or 12 years, but may be given beginning at age 9 years through age 26 | 2-dose series: Ages 9 to 14 years, with second dose 6 to 12 months after the first 3-dose series: Ages 15 to 26, with the second dose given 2 months after the first dose, and the third dose given 6 months after the first dose |
Inactivated poliovirus | All children | A final dose between ages 4 and 6 years |
Influenza (flu) | All children in this age group | Once a year |
Measles, mumps, rubella (MMR) | All children | Second dose between ages 4 and 6 years |
Meningococcal (conjugate) | All children | 1 dose between ages 11 and 12, and a booster at age 16, or by age 18 if not vaccinated before; only 1 dose is needed if the first dose is given at age 16 years or older; high-risk children should receive a vaccine series before age 2 years |
Pneumococcal conjugate (PCV13) and pneumococcal polysaccharide (PPSV23) | Healthy children between ages 18 months and 5 years may get PCV13 if not received at a younger age; high-risk children may receive PCV13 starting at age 5 years and PPSV23 starting at age 2 years | PCV13 is given before PPSV23; The timing and number of doses varies |
Counseling | Who needs it | How often |
|---|
Depression | Children between ages 12 and 18 years | At routine exams |
Prevention of sexually transmitted infections | Children in this age group who are sexually active | At routine exams |
Prevention of skin cancer | Fair-skinned children starting at age 10 years | At routine exams |
Increased physical activity | Children with diabetes or prediabetes | At routine exams |